A Multidisciplinary Approach to CAR T-cell Therapy for Adult Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia - Episode 2

Navigating Treatment Selections for B-ALL: Insights From the Moffitt Cancer Center

Experts discuss the key factors influencing product selection in treatment choices at their center, emphasizing clinical efficacy, patient safety, cost-effectiveness, and personalized care.

Video content above is prompted by the following:

When faced with multiple treatment choices, what factors are of paramount consideration in product selection at your center?